Current Affairs - April, 2020

ICMR: Remdesvir effective in stopping replication mechanism of COVID-19

On April 13, 2020, the Indian Council of Medical Research announced that the antiviral drug Remdesvir is highly effective in stopping the replication of COVID-19. Highlights The research on the efficacy of Remdesvir is a part of WHO’s “Solidarity Trial”. The efficacy of Remdesvir is not based on clinical trials. However, ICMR is concluding its Read More…

Pradhan Mantri Garib Kalyan Yojana: 32 Crore receive financial assistance

Under Pradhan Mantri Garib Kalyan Yojana, more than 32 crore have received financial assistance so far. Highlights The scheme has benefitted the public in the following ways 29 Cores of beneficiaries have been distributed free food grains. 8 lakhs have received free cylinders under Pradhan Mantri Ujjwala Yojana Rs 7.47 crore transferred under Pradhan Mantri Read More…

Curbs on Palm oil imports tightened

On April 13, 2020, India tightened its curbs on imports of palm oil. Under the new conditions, the authorisation for imports of palm oil should be accompanied with pre-purchase agreement. Highlights Apart from the pre-purchase agreement, “certificate of origin” has also been made mandatory. This certificate is important to prove where the goods come from. Read More…

First Ship load of Crude Oil reaches India

On April 13, 2020, the first crude oil of 1 million barrels from UAE have reached India. The oil prices have declined by 60% since January, 2020. The prices are expected to rise with OPEC and Russia have come to terms to cut their production by 10%. Hence, this is the right time to fill Read More…

Core Strategy Group formed in CSIR

On April 13, 2020, a core strategy group was formed in CSIR (Council of Scientific and Industrial Research). The group will work towards rapid and economical diagnostics, digital and molecular surveillance and repurposing of drugs. Concerns The GoI has not yet displayed list of dedicated hospitals for COVID-19. For now, when a person is suspicious Read More…